Showing results (91-100 of 292) with videos related to

Sort By:
Pageof 30
Drug and Alcohol Dependence|January 18, 2006
Pharmaco-economics of community maintenance for opiate dependence: a review of evidence and methodologySteven Simoens, Anne Ludbrook, Catriona Matheson, et al.
Orphanet Journal of Rare Diseases|October 11, 2013
Development and validation of COMPASS: clinical evidence of orphan medicinal products - an assessment toolEline Picavet, David Cassiman, Bert Aertgeerts, et al.
American Journal of Pharmaceutical Education|July 11, 2007
International trends in lifelong learning for pharmacistsAnnelies Driesen, Koen Verbeke, Steven Simoens, et al.
BMC Health Services Research|September 27, 2014
Drug shortages in European countries: a trade-off between market attractiveness and cost containment?Kim Pauwels, Isabelle Huys, Minne Casteels, et al.
Frontiers in Pharmacology|May 10, 2021
Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic ReviewKhadidja Abdallah, Isabelle Huys, Kathleen Claes, et al.
Frontiers in Pharmacology|May 31, 2021
How to Value Orphan Drugs? A Review of European Value Assessment FrameworksAlessandra Blonda, Yvonne Denier, Isabelle Huys, et al.
Frontiers in Pharmacology|June 18, 2016
Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology DrugsKim Pauwels, Isabelle Huys, Minne Casteels, et al.
Health Policy (Amsterdam, Netherlands)|December 1, 2009
A comparative analysis of remuneration models for pharmaceutical professional servicesCecilia Bernsten, Karolina Andersson, Yves Gariepy, et al.
Drugs|July 4, 2012
Orphan drugs for rare diseases: is it time to revisit their special market access status?Steven Simoens, David Cassiman, Marc Dooms, et al.
Pharmacy World & Science : PWS|April 1, 2009
Patient experiences of over-the-counter medicine purchases in Flemish community pharmaciesSteven Simoens, Marieke Lobeau, Koen Verbeke, et al.
Pageof 30